These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 25408490)

  • 1. Adjusting relative survival estimates for cancer mortality in the general population.
    Ellison LF
    Health Rep; 2014 Nov; 25(11):3-9. PubMed ID: 25408490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimating relative survival for cancer: An analysis of bias introduced by outdated life tables.
    Ellison LF
    Health Rep; 2014 Feb; 25(2):13-9. PubMed ID: 24567246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leading cancers--changes in five-year relative survival.
    Ellison LF; Gibbons L
    Health Rep; 2004 Mar; 15(2):19-32. PubMed ID: 15151028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer survival in five continents: a worldwide population-based study (CONCORD).
    Coleman MP; Quaresma M; Berrino F; Lutz JM; De Angelis R; Capocaccia R; Baili P; Rachet B; Gatta G; Hakulinen T; Micheli A; Sant M; Weir HK; Elwood JM; Tsukuma H; Koifman S; E Silva GA; Francisci S; Santaquilani M; Verdecchia A; Storm HH; Young JL;
    Lancet Oncol; 2008 Aug; 9(8):730-56. PubMed ID: 18639491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in the survival of patients diagnosed with cancer in the Nordic countries 1964-2003 followed up to the end of 2006. Material and methods.
    Engholm G; Gislum M; Bray F; Hakulinen T
    Acta Oncol; 2010 Jun; 49(5):545-60. PubMed ID: 20491523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of state-specific life tables on relative survival.
    Stroup AM; Cho H; Scoppa SM; Weir HK; Mariotto AB
    J Natl Cancer Inst Monogr; 2014 Nov; 2014(49):218-27. PubMed ID: 25417235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Five-year relative survival from prostate, breast, colorectal and lung cancer.
    Ellison LF; Gibbons L;
    Health Rep; 2001 Dec; 13(1):23-34. PubMed ID: 15069806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating expected survival probabilities for relative survival analysis--exploring the impact of including cancer patient mortality in the calculations.
    Talbäck M; Dickman PW
    Eur J Cancer; 2011 Nov; 47(17):2626-32. PubMed ID: 21924892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expected years of life lost for six potentially preventable cancers in the United States.
    Liu PH; Wang JD; Keating NL
    Prev Med; 2013 May; 56(5):309-13. PubMed ID: 23428566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression of mean age and mean expected mortality rate by duration of follow up in cohorts with a wide range of age.
    Singer RB
    J Insur Med; 2006; 38(3):181-91. PubMed ID: 17076138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Choice of relative or cause-specific approach to cancer survival analysis impacts estimates differentially by cancer type, population, and application: evidence from a Canadian population-based cohort study.
    Withrow DR; Pole JD; Nishri ED; Tjepkema M; Marrett LD
    Popul Health Metr; 2017 Jul; 15(1):24. PubMed ID: 28673318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Italian cancer figures, report 2012: Cancer in children and adolescents.
    ; ;
    Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in cancer survival in Canada by sex.
    Ellison LF
    Health Rep; 2016 Apr; 27(4):19-27. PubMed ID: 27096620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bias in relative survival methods when using incorrect life-tables: lung and bladder cancer by smoking status and ethnicity in New Zealand.
    Blakely T; Soeberg M; Carter K; Costilla R; Atkinson J; Sarfati D
    Int J Cancer; 2012 Sep; 131(6):E974-82. PubMed ID: 22419246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Timely disclosure of progress in long-term cancer survival: the boomerang method substantially improved estimates in a comparative study.
    Brenner H; Jansen L
    J Clin Epidemiol; 2016 Feb; 70():224-32. PubMed ID: 26456902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data.
    Coleman MP; Forman D; Bryant H; Butler J; Rachet B; Maringe C; Nur U; Tracey E; Coory M; Hatcher J; McGahan CE; Turner D; Marrett L; Gjerstorff ML; Johannesen TB; Adolfsson J; Lambe M; Lawrence G; Meechan D; Morris EJ; Middleton R; Steward J; Richards MA;
    Lancet; 2011 Jan; 377(9760):127-38. PubMed ID: 21183212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival from cancer--up-to-date predictions using period analysis.
    Ellison LF; Gibbons L
    Health Rep; 2006 May; 17(2):19-30. PubMed ID: 16716033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stage at diagnosis and early mortality from cancer in England.
    McPhail S; Johnson S; Greenberg D; Peake M; Rous B
    Br J Cancer; 2015 Mar; 112 Suppl 1(Suppl 1):S108-15. PubMed ID: 25734389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer net survival on registry data: use of the new unbiased Pohar-Perme estimator and magnitude of the bias with the classical methods.
    Roche L; Danieli C; Belot A; Grosclaude P; Bouvier AM; Velten M; Iwaz J; Remontet L; Bossard N
    Int J Cancer; 2013 May; 132(10):2359-69. PubMed ID: 22961565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjusting for the proportion of cancer deaths in the general population when using relative survival: a sensitivity analysis.
    Hinchliffe SR; Dickman PW; Lambert PC
    Cancer Epidemiol; 2012 Apr; 36(2):148-52. PubMed ID: 22000329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.